MINDMAZE THERAPEUTICS HOLDING SA Cash Flow-to-Debt Ratio

Latest as of December 2025: -0.55x

MINDMAZE THERAPEUTICS HOLDING SA cash flow-to-debt ratio. MINDMAZE THERAPEUTICS HOLDING SA (MMTX) has a Cash Flow-to-Debt Ratio of -0.55x as of December 2025, meaning its operating cash flow of CHF-7.21 Million could theoretically repay -1% of its total liabilities (CHF13.19 Million) in one year. See MMTX free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

CF-to-Debt Ratio

-0.55x
Operating CF / Total Liabilities

Operating Cash Flow

CHF-7.21 Million
CHF

Total Liabilities

CHF13.19 Million
CHF

Data as of

Dec 2025
Most recent filing

Cash Flow-to-Debt Ratio of MINDMAZE THERAPEUTICS HOLDING SA (2024–2025)

Cash flow-to-debt ratio of MINDMAZE THERAPEUTICS HOLDING SA from 2024 to 2025. Historical debt coverage capacity for MINDMAZE THERAPEUTICS HOLDING SA across 2 annual periods. Also explore MMTX shareholders equity momentum to track the company's year-over-year net asset growth rate.

MINDMAZE THERAPEUTICS HOLDING SA Cash Flow-to-Debt Ratio by Year (2024–2025)

MINDMAZE THERAPEUTICS HOLDING SA cash flow-to-debt ratio by year from 2024 to 2025. Year-by-year debt coverage analysis for MINDMAZE THERAPEUTICS HOLDING SA. For the full cash flow conversion analysis, see MINDMAZE THERAPEUTICS HOLDING SA operating cash flow efficiency.

Year CF-to-Debt Ratio Operating CF (CHF) Total Liabilities YoY Change
2025 -0.55x CHF-7.21 Million CHF13.19 Million ▼ -27.5%
2024 -0.43x CHF-3.00K CHF7.00K —
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.